Exemptia 40 mg prefilled syringe is used to treat certain types of arthritis (inflammatory disorder that typically affects the small joints in hands and feet) including -
Adalimumab is a potent TNF-inhibitor and anti-inflammatory drug manufactured by Zydus Cadila. It binds to tumor necrosis factor-alpha (TNF). TNF normally binds to TNF receptors, which leads to the inflammatory response of autoimmune diseases. By binding to TNF, Exemptia reduces this inflammatory response. The TNF-inhibitor affects the bodys defense system, i.e. the immune system that protects the body from infection.
Developed and Managed by Infocom Network Private Limited.